Top compounds associated with response to PRAMEF18


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib gCSI pan-cancer AAC -0.058 0.3
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.035 0.3
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.038 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.3
mRNA KPT185 CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.034 0.3
mRNA KU-0063794 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA pitstop2 CTRPv2 pan-cancer AAC -0.045 0.3
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
Download CSV